Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Dev Biol. 2018 Jul 30;442(1):138–154. doi: 10.1016/j.ydbio.2018.07.009

Figure 6.

Figure 6.

Expression profiles of pro-inflammatory macrophage markers in LPStreated/M1 and IL-4 treated/M2 macrophages A. iNOS expression was significantly upregulated in untreated BMDMs and LPS treated EMs/BMDMs and attenuated in IL-4 treated EMs /BMDMs as compared to untreated EMs. B. CD11b expression was significantly up-regulated in LPS treated EMs/BMDMs and attenuated in IL-4 treated EMs/BMDMs as compared to untreated EMs. C. TNF expression was significantly upregulated in untreated BMDMs, LPS treated EMs/BMDMs and attenuated in IL-4 treated EMs/BMDMs as compared to untreated EMs. D. CCR2 expression was significantly upregulated in IL-4 treated EMs, untreated BMDMs, LPS and IL-4 treated BMDMs, but no statistically significant differences were observed in LPS treated EMs compared to untreated EMss. Error bars indicate SE of the mean. N=3.